Skip to main content

Update on Annette

Today I’m feeling much better about Annette’s situation. Not that things aren’t very serious, but I’m really pleased with the care she’s getting at KUMed. I think she is as well. The doctors are telling her she has the AML type of leukemia, but that they think they’ve caught it early and they think it’s confined to the bone marrow.

She’s been scanned and gone over every which way these past few days as the doctors check to make sure there isn’t any other cancer anywhere. So far every test has come back clean. They’ve also been completely checking out every organ system before they start Annette on chemotherapy. Everyone seems very upbeat about her long term prognosis, although it’s going to be a tough year ahead.

The kids will be going to Nebraska to stay with their grandparents and will be enrolled in school there for now. They are telling Annette that even when she gets out of the hospital in about six weeks, she won’t be up to caring for two small children – not to mention the bugs and germs kids bring home from daycare and school. That’s going to be really hard on her. When I spoke to her today that was the one thing she got emotional about.

I was also very interested to hear that the docs at KU are convinced she never had Lupus or COPD – I’m not sure, however, what they think has been going on though. I was interested to hear they’d been in asking a lot of family history questions so sounds like they were looking at the role of genetics – but there isn’t anyone else in the family with the same issues.

At any rate, it sounds like they’re on top of things. They’ve also been talking to Annette about how to talk to the kids about what’s going on, which I was very happy about.

I haven’t yet been able to see her, but I have an immunologist and allergist appointment at KUMed on Wednesday – so when I’m finished I’m hoping to be able to visit.

Comments

Care said…
I'm glad the outlook for your friend is a little more positive. I will add her to my prayer list.

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria